It was almost exactly a year ago when then-candidate Donald Trump raised a few eyebrows by confirming — out loud and on camera — that he was “looking at” possible restrictions on contraception. The Republican eventually walked that back, though they were not his only election-season comments on the issue.
In fact, in early August 2024, Trump said at a press conference that he wouldn’t rule out revoking access to mifepristone, one of the two drugs used in medication abortions, saying that as far as he was concerned, there were “absolutely” ways to effectively ban the pill in a “humane” way.
It was against this backdrop that HuffPost reported this week:
Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone. Makary’s letter is in response to an April request from Hawley for the department to review mifepristone following a new report published by the Ethics and Public Policy Center, an anti-abortion conservative think tank and advisory board member of Project 2025.
For those unfamiliar with the medication, the FDA approved mifepristone about a quarter of a century ago, to be used as part of a two-step process to terminate unwanted pregnancies up to 10 weeks. The drug has proven to be safe, effective and commonly used.
It’s nevertheless become a popular target for opponents of reproductive rights, including a notorious Trump-appointed judge in Texas who curtailed access to the drug (though he was later overturned by the U.S. Supreme Court).








